MARKET

ACER

ACER

Acer Therapeutic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.530
-0.190
-11.05%
After Hours: 1.740 +0.21 +13.73% 17:23 04/03 EDT
OPEN
1.700
PREV CLOSE
1.720
HIGH
1.770
LOW
1.500
VOLUME
46.49K
TURNOVER
--
52 WEEK HIGH
28.25
52 WEEK LOW
1.080
MARKET CAP
15.45M
P/E (TTM)
-0.5248
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ACER stock price target is 9.00 with a high estimate of 10.00 and a low estimate of 8.00.

EPS

ACER News

More
  • Acer Therapeutics: EDSIVO Appeal Denied But FDA Door Remains Open
  • Seeking Alpha - Article · 03/25 15:21
  • NGL, PLAY, ACER and APDN among midday movers
  • Seeking Alpha - Article · 03/19 16:45
  • Acer Receives Formal Dispute Resolution Request (FDRR) Response from FDAs Office of New Drugs
  • GlobeNewswire · 03/18 21:05
  • Acer Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
  • GlobeNewswire · 03/18 21:05

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About ACER

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The Company is developing Edsivo for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the United States. The Company is developing ACER-001, a pharmacologic treatment option for the treatment of Maple Syrup Urine Disease (MSUD). ACER-001 is an immediate-release formulation of sodium phenylbutyrate (NaPB) developed using a microencapsulation process. The Company is also developing ACER-001 for the treatment of Urea Cycle Disorders (UCD).
More

Webull offers kinds of Acer Therapeutics Inc stock information, including NASDAQ:ACER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACER stock news, and many more online research tools to help you make informed decisions.